Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics

Overview of attention for article published in Metabolomics, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 22 X posts from 17 X users, with an upper bound of 32,481 followers.

RT @metabolomics: Monitoring cancer prognosis, diagnosis and treatment efficacy with #Pharmacometabolomics https://t.co/tQ0xRrBr5y

RT @metabolomics: Monitoring cancer prognosis, diagnosis and treatment efficacy with #Pharmacometabolomics https://t.co/tQ0xRrBr5y

RT @metabolomics: Monitoring cancer prognosis, diagnosis and treatment efficacy with #Pharmacometabolomics https://t.co/tQ0xRrBr5y

Monitoring cancer prognosis, diagnosis and treatment efficacy with #Pharmacometabolomics https://t.co/tQ0xRrBr5y

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.